The biomedical industry is one of the three key industries in Shanghai. In order to further accelerate the high-quality development of Shanghai’s biomedical industry, the Municipal Development and Reform Commission works with the Municipal Economic Information Commission, Municipal Science and Technology Commission, Municipal Health Commission, and Municipal Drug Administration 16 departments have studied and formulated a new round of opinions on promoting the high-quality development of the city’s biomedicine industry, which have been issued by the General Office of the Municipal Government.
        At the municipal government press conference, Hua Yuan, deputy secretary-general of the municipal government and director of the municipal development and reform commission, introduced the main information of the "Several Opinions on Promoting the High-quality Development of the Municipal Biomedical Industry".
        Among them, regarding the launch of the "Zhangjiang R&D + Shanghai Manufacturing" brand, the following opinions are put forward:
        1. Improve the modernization level of the industrial chain. For core technology research in the field of biomedicine, the construction of key specialized service platforms, and major product industrialization projects, no more than 30% of the approved new investment and a maximum of 15 million yuan will be given. Major projects are included in the city’s special projects for the development of strategic emerging industries, with a maximum of 100 million yuan in financial support. Relying on the Municipal Science and Technology Innovation Action Plan, continue to support the research and development of drugs and medical devices.
        2. Promote the digital, intelligent, and green transformation of the manufacturing industry. Promote the in-depth integration of a new generation of information technology and manufacturing, and provide financial support of no more than 20% of the total investment or contract amount of the approved project and a maximum of 10 million yuan. Encourage enterprises to strengthen high-end, intelligent, and green transformations, and give no more than 10% of the total investment in the approved project, with a maximum of 50 million yuan in financial support. Promote the research of continuous drug manufacturing review standards, promote technology application demonstration, and encourage the development of green and miniaturized production equipment and processes such as micro-reactors.
        3. Promote new models such as contract R&D and production organization. Encourage contract production organization (CMO) or contract research and development production organization (CDMO) to entrust R&D and production activities, and give 20% of the first transaction contract amount for a single product produced by the entrusted enterprise (the entrusting parties must have no investment connection) , Up to 5 million yuan in financial support; a single enterprise supports up to 10 million yuan each year. Qualified Chinese medicine production enterprises in this city are allowed to conduct scientific research, production and clinical use of Chinese medicine prescription granules, and encourage the construction of a standardization system for Chinese medicine.
        4. orderly enhance the industrial space carrying capacity. The relevant district governments quantify and decompose the new industrial and property space indicators of the municipal biomedical characteristic parks in the district in the next 3 to 5 years. The Municipal Biomedical Industry Development Leading Group (hereinafter referred to as the "Leading Group") office has implemented the indicators Perform year-by-year assessments. On the premise of conforming to the industrial function orientation and the project's leading industrial use, the pilot in Zhangjiang Science City and Lingang New Area allows the transferee to independently determine the proportion of land industrial use.
        5. Optimize the environmental access management of biomedicine. For qualified biomedical parks, accelerate the promotion of the linkage between the planning and project environmental impact assessment, and simplify the environmental impact assessment process. Major industrial projects at the municipal level enjoy green approval channels, and the total pollutant emission indicators are adjusted from the three-level allocation to the overall planning of the whole district or the whole city. For professional institutions dealing with hazardous waste in the biomedical park, all districts are encouraged to provide subsidies based on the amount of hazardous waste disposed of.。
        6. Promote the characteristic development of the park and regional linkage and cooperation. Optimize the layout of the biopharmaceutical industry base, focus on building the Zhangjiang biopharmaceutical industry cluster led by the "Zhangjiang Medicine Valley", and continue to build 5 cluster development industrial bases in Lingang New Area, Fengxian, Jinshan, Baoshan, and Minhang. Qingpu, Jiading, Putuo and other districts cultivate characteristic industrial carriers; strengthen the guidance and coordination of cross-district industrial cooperation projects, accelerate the construction of a full-chain industrial information platform, and explore and improve district cooperation and benefit-sharing mechanisms.
        Implementation period: The "Several Opinions" will be implemented from June 1, 2021, and will be valid until May 31, 2024.